Healthcare exoskeletons or medical exoskeletons are also known as a wearable robot. These are used to restore locomotion as well as improve the physical activity by increasing standing & walking time for patients with the muscular impairments. They are worn outside the body of individuals and generally consist of rigid parts or hardware including sensor and actuator, and robotic software. These exoskeletons benefit various patients by bowel or bladder control, and bone-density to improve their endurance, and reducing the chances of increasing urinary tract infections. Additional benefits include improved circulation, increased oxygen intake, decrease in body fat percentage, improved cardiovascular & metabolic functions, decreased pain, and improved sitting posture. Therefore, such advantages of healthcare exoskeletons during rehabilitation will considerably influence healthcare exoskeleton market growth during the forecast period.
As per study, “Europe Healthcare Exoskeletons Market by Application, Mobility Type, Product Function, Power Technology, and Country 2018-2023: Growth Opportunity and Business Strategy” key companies operating in the Europe healthcare exoskeletons market are AlterG, Inc., Honda Motor Co., Ltd., Bionik Laboratories Corp., Panasonic Corporation (Activelink, Cyberdyne, Inc., Ekso Bionics, Parker Hannifin Corporation, Hocoma, ReWalk Robotics Ltd., Myomo, U.S. Bionics, Inc. (suitX), Rex Bionics Plc.
By application, Europe healthcare exoskeletons market is segregated as mobility aid, rehabilitation and others. By mobility type, market is segregated as stationary exoskeleton, mobile exoskeleton and tethered exoskeleton. By product function, market is segregated as lower body exoskeleton and upper body exoskeleton. In addition, by power technology, market is segregated as active exoskeleton and passive exoskeleton. Active exoskeleton includes pneumatic actuator, fuel cell, electric actuator, hydraulic actuator and others.
Increasing number of people across the Europe with lower limb disorders is augmenting the need or mobility aid & assistive healthcare devices. The growing morbidity along with health burden of disorders for instance cerebral embolisms and spinal cord injuries are notable factors for driving the demand of healthcare exoskeleton. The requirement of these exoskeletons is substantial among geriatrics in all major cities of region. Rising demand for innovative rehabilitation approaches has posited growing focus of the medical community on healthcare exoskeleton, thus fueling the rapid expansion of the European market.
Increasing insurance coverage for assistive devices is gradually more benefiting the patient population, thus catalyzing the growth of the Europe healthcare exoskeleton market. Several manufacturers & insurance providers are focused on increasing their reimbursement policies to favor the uptake of healthcare exoskeleton as assistive devices. Advances made in healthcare robotics have made healthcare or medical exoskeleton devices smarter, driving innovations in the market. The advent of modular healthcare exoskeleton or devices with intuitive interface is a vital case in point.
By geography, Europe healthcare exoskeletons market is segregated as UK, France, Germany, Spain, Italy, and rest of Europe. It is estimated that future of the Europe healthcare exoskeletons market will be bright owing to presence of advanced healthcare facilities, increase in adoption of exoskeletons in a magnitude of healthcare applications, growth in geriatric & physically disabled population coupled with large population base in the region.
For More Information, click on the link below:-
Ankur Gupta, Head Marketing & Communications